These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21199184)

  • 1. Liver toxicity possibly related with ropinirole use in the treatment of restless legs syndrome.
    Navacerrada F; González-Alonso MR; Alonso-Navarro H; Pilo-de-la-Fuente B; Plaza-Nieto JF; Jiménez-Jiménez FJ
    Eur J Neurol; 2011 Jun; 18(6):e65. PubMed ID: 21199184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ropinirole treatment of restless legs].
    Kinge E; Lossius MI; Mowincel P
    Ugeskr Laeger; 2005 Mar; 167(11):1284-6. PubMed ID: 15830500
    [No Abstract]   [Full Text] [Related]  

  • 3. Ropinirole (Requip) for restless legs syndrome.
    Med Lett Drugs Ther; 2005 Aug; 47(1214):62-4. PubMed ID: 16052162
    [No Abstract]   [Full Text] [Related]  

  • 4. Ropinirole-induced symptomatic sinus node dysfunction.
    Szymanski C; Boey S; Hermida JS
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):1079-82. PubMed ID: 18684270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole (Requip) for restless legs syndrome.
    Obstet Gynecol; 2006 Jan; 107(1):176-8. PubMed ID: 16394057
    [No Abstract]   [Full Text] [Related]  

  • 6. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of ropinirole-treated restless leg syndrome (RLS) during smoking cessation.
    Juergens TM
    J Clin Sleep Med; 2008 Aug; 4(4):371-2. PubMed ID: 18763430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.
    Konofal E; Arnulf I; Lecendreux M; Mouren MC
    Pediatr Neurol; 2005 May; 32(5):350-1. PubMed ID: 15866437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ropinirole in the treatment of restless legs].
    Hellebek A; Kampmann JP
    Ugeskr Laeger; 2005 Jun; 167(23):2541; author reply 2541-2. PubMed ID: 16008015
    [No Abstract]   [Full Text] [Related]  

  • 11. Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
    Launois C; Leu-Semenescu S; Brion A; Arnulf I
    Sleep Med; 2013 Jul; 14(7):696. PubMed ID: 23714418
    [No Abstract]   [Full Text] [Related]  

  • 12. Ropinirole treatment for restless legs syndrome.
    Molnar MZ; Fornadi K; Shapiro CM
    Drugs Today (Barc); 2006 Sep; 42(9):587-98. PubMed ID: 17028668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid-induced hyperalgesia and dopamine-induced augmentation in an intractable and refractory case of RLS.
    Chokroverty S
    Sleep Med; 2015 Oct; 16(10):1304. PubMed ID: 26386895
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychosis related to ropinirole.
    Perea E; Robbins BV; Hutto B
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513886
    [No Abstract]   [Full Text] [Related]  

  • 15. Punding in patients on dopamine agonists for restless leg syndrome.
    Evans AH; Stegeman JR
    Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926
    [No Abstract]   [Full Text] [Related]  

  • 16. A Retrospective, Pooled Suicidality Evaluation of Ropinirole Immediate Release and Controlled Release for the Treatment of Restless Legs Syndrome.
    Makumi CW; Paska W; Rolfe K; Shulman KJ
    Clin Ther; 2015 May; 37(5):1122-7. PubMed ID: 25869628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome.
    Dorfman BJ; Nirenberg MJ
    Parkinsonism Relat Disord; 2013 Feb; 19(2):269-70. PubMed ID: 22749683
    [No Abstract]   [Full Text] [Related]  

  • 18. Ropinirole for restless legs syndrome: a placebo-controlled crossover trial.
    Adler CH; Hauser RA; Sethi K; Caviness JN; Marlor L; Anderson WM; Hentz JG
    Neurology; 2004 Apr; 62(8):1405-7. PubMed ID: 15111683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS.
    Chopra A; Pendergrass DS; Bostwick JM
    Psychosomatics; 2011; 52(1):92-4. PubMed ID: 21300203
    [No Abstract]   [Full Text] [Related]  

  • 20. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.